Global $4.9 Billion Automatic Content Recognition (ACR) Markets to 2027: Evolving Concept of Contextual Advertising, Commerce, Experiences, and Spoiler-Proof Social Feeds Presents Opportunities
June 23, 2022 04:48 ET
|
Research and Markets
Dublin, June 23, 2022 (GLOBE NEWSWIRE) -- The "Global Automatic Content Recognition Market by Component, Content, Technology, Applications (Broadcast Monitoring and AD Targeting & Pricing),...
Exagen Showcases Eight Scientific Presentations at ACR’s Virtual Annual Meeting in November 2021
October 21, 2021 16:05 ET
|
Exagen Inc.
SAN DIEGO, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today it will be presenting new scientific research at the...
Equillium to Present Data at the 2020 American College of Rheumatology Meeting Demonstrating CD6 Modulation Improves Kidney and Skin Pathology in Preclinical Models of Systemic Lupus Erythematosus
November 04, 2020 08:35 ET
|
Equillium
Studies further validate ongoing clinical development of itolizumab for the treatment of systemic lupus erythematosus and lupus nephritis LA JOLLA, Calif., Nov. 04, 2020 (GLOBE NEWSWIRE) --...
Biogen to Present Positive Phase 2 Systemic Lupus Erythematosus Data at American College of Rheumatology 2020 Meeting
November 03, 2020 07:30 ET
|
Biogen Inc.
In Phase 2 LILAC study, BIIB059 demonstrated a statistically significant reduction in joint disease activity compared to placebo in systemic lupus erythematosus patientsPositive results build on...
Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2019 Financial Results
March 12, 2020 07:05 ET
|
Corbus Pharmaceuticals Holdings, Inc.
Topline results for Phase 3 study in systemic sclerosis on schedule for summer of 2020 followed by Phase 2b study results in cystic fibrosis Completed $46 million public offering in February...
Equillium to Present New Data and Insights on the CD6-ALCAM Pathway in Lupus Nephritis at ACR 2019
November 06, 2019 08:05 ET
|
Equillium
LA JOLLA, Calif., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat...
Cisco 2018 Annual Cybersecurity Report Reveals Security Leaders Rely on and Invest in Automation, Machine Learning and Artificial Intelligence to Defend Against Threats
February 21, 2018 08:00 ET
|
Cisco
SAN JOSE, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Malware sophistication is increasing as adversaries begin to weaponize cloud services and evade detection through encryption, used as a tool to...
Levolta Pharmaceuticals Presents Phase II Study Results for Potential Osteoarthritis Therapy at ACR Annual Meeting
November 18, 2014 11:00 ET
|
Levolta Pharmaceuticals, Inc.
BETHLEHEM, Pa., Nov. 18, 2014 (GLOBE NEWSWIRE) -- Levolta Pharmaceuticals, Inc. today presented the results of an exploratory Phase II study for a potential disease modifying drug for patients with...
Axwave Inc. Is a Finalist for the 2014 Red Herring Top 100 North America Award
May 07, 2014 14:32 ET
|
Axwave Inc.
PALO ALTO, CA--(Marketwired - May 07, 2014) - Axwave Inc. announced today it had been selected as a finalist for Red Herring's Top 100 North America award, a prestigious list...
GSOUND Transforms the Way We Watch TV by Connecting Us to Over 250 US TV Channels
April 16, 2014 14:04 ET
|
Axwave Inc.
PALO ALTO, CA--(Marketwired - April 16, 2014) - Axwave Inc., creator of GSOUND, the newest, most innovative mobile app that brings people closer to the movies, music...